BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 33128201)

  • 21. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
    Radner H; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
    Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
    Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
    Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Behçet disease with psoriasis and psoriatic arthritis.
    Hahn HJ; Kwak SG; Kim DK; Kim JY
    Sci Rep; 2021 Jan; 11(1):2531. PubMed ID: 33510251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure.
    Burmester GR; Nash P; Sands BE; Papp K; Stockert L; Jones TV; Tan H; Madsen A; Valdez H; Cohen SB
    RMD Open; 2021 May; 7(2):. PubMed ID: 34045358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
    Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
    Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database.
    Pina Vegas L; Penso L; Claudepierre P; Sbidian E
    JAMA Dermatol; 2022 May; 158(5):513-522. PubMed ID: 35319735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
    Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study.
    Kiltz U; Sfikakis PP; Gaffney K; Sator PG; von Kiedrowski R; Bounas A; Gullick N; Conrad C; Rigopoulos D; Lespessailles E; Romanelli M; Ghislain PD; Brandt-Jürgens J; Rashkov R; Aassi M; Orsenigo R; Perella C; Pournara E; Gathmann S; Jagiello P; Veit J; Augustin M
    Adv Ther; 2020 Jun; 37(6):2865-2883. PubMed ID: 32378070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?
    Löfvendahl S; Petersson IF; Theander E; Svensson Å; Zhou C; Steen Carlsson K
    J Rheumatol; 2016 Mar; 43(3):640-7. PubMed ID: 26773111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States.
    Merola JF; Tian H; Patil D; Richardson C; Scott A; Chen YH; Kim N; Hur P; Armstrong AW
    J Am Acad Dermatol; 2022 Apr; 86(4):748-757. PubMed ID: 34547358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiology of pediatric psoriasis: A nationwide cohort study in Taiwan.
    Lin TL; Fan YH; Chang YL; Ho HJ; Wu CY; Chen YJ
    J Dermatol; 2024 Jan; 51(1):48-55. PubMed ID: 37870277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
    Sheahan A; Anjohrin S; Suruki R; Stark JL; Sloan VS
    Clin Rheumatol; 2024 Jun; 43(6):1897-1907. PubMed ID: 38658403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    van der Voort EAM; Wakkee M; Veldt-Kok P; Darwish Murad S; Nijsten T
    Br J Dermatol; 2017 Jun; 176(6):1599-1606. PubMed ID: 27925155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
    Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
    Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
    Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
    Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaco-utilization of biologic drugs in patients affected by psoriasis, psoriatic arthritis and ankylosing spondylitis in an Italian real-world setting.
    Zagni E; Colombo D; Fiocchi M; Perrone V; Sangiorgi D; Andretta M; De Sarro G; Nava E; Degli Esposti L
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):491-497. PubMed ID: 32701033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.